Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Long-Term Investments (2016 - 2017)

Historic Long-Term Investments for Tenax Therapeutics (TENX) over the last 3 years, with Q3 2017 value amounting to $2.3 million.

  • Tenax Therapeutics' Long-Term Investments fell 8683.32% to $2.3 million in Q3 2017 from the same period last year, while for Sep 2017 it was $2.3 million, marking a year-over-year decrease of 8683.32%. This contributed to the annual value of $8.6 million for FY2016, which is N/A changed from last year.
  • Tenax Therapeutics' Long-Term Investments amounted to $2.3 million in Q3 2017, which was down 8683.32% from $3.3 million recorded in Q2 2017.
  • Tenax Therapeutics' Long-Term Investments' 5-year high stood at $19.6 million during Q2 2016, with a 5-year trough of $2.3 million in Q3 2017.
  • Its 3-year average for Long-Term Investments is $10.7 million, with a median of $8.6 million in 2016.
  • In the last 5 years, Tenax Therapeutics' Long-Term Investments crashed by 5234.98% in 2016 and then crashed by 8683.32% in 2017.
  • Over the past 3 years, Tenax Therapeutics' Long-Term Investments (Quarter) stood at $18.0 million in 2015, then crashed by 52.35% to $8.6 million in 2016, then crashed by 72.93% to $2.3 million in 2017.
  • Its Long-Term Investments stands at $2.3 million for Q3 2017, versus $3.3 million for Q2 2017 and $5.2 million for Q1 2017.